Possible neurological and mental COVID-19 outcomes related to the angiotensin-converting enzyme 2/Mas/brain-derived neurotrophic factor (ACE2/Mas/BDNF) signaling pathway occupation by SARS-CoV-2
Possible neurological and mental COVID-19 outcomes related to the angiotensin-converting enzyme 2/Mas/brain-derived neurotrophic factor (ACE2/Mas/BDNF) signaling pathway occupation by SARS-CoV-2. ACE, angiotensin-converting enzyme; At2R, angiotensin 2 receptor; Bax, Bcl-2-associated X protein; Bcl2, B-cell lymphoma 2; eNOS, endothelial nitric oxide synthase; GPX, glutathione peroxidase; GR, glutathione reductase; IL-1β, interleukin 1 beta; MDA, malonaldehyde; NO, nitric oxide; SOD, superoxide dismutase; TMPRSS2, type II transmembrane serine protease 2; and TNF-α, tumor necrosis factor alfa; ↓ increase; ↑ decrease